Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.905
-0.095 (-1.90%)
At close: Sep 4, 2025, 4:00 PM
4.910
+0.005 (0.10%)
After-hours: Sep 4, 2025, 4:10 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $303.24 million as of September 4, 2025. Its market cap has increased by 5.58% in one year.
Market Cap
303.24M
Enterprise Value
53.78M
1-Year Change
5.58%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $303.24M, a decrease of -64.13%. That is a compound annual growth rate of -21.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 308.80M | -27.57% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |